Dr. Bernhard Hampl joins ChemWerth Board of Directors
Peter Werth, the President and CEO of US-based ChemWerth Inc, announced that Dr. Bernhard Hampl has joined the company’s board of directors.
Dr. Hampl, received his Ph.D. in pharmaceutical chemistry from Ludwig-Maximillians University in Munich and his career has included working for Cyanamid GmbH where he served as the company's director of research and development and technical director; Chief Executive Officer of Eon Labs; and, President and CEO of Sandoz U.S. While CEO of Sandoz, Dr. Hampl also served as a member of the Executive Board of the Generic Pharmaceutical Association, especially advocating a pathway to the approval and future use of bio-generics.
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.